Alibaba Faces Securities Fraud Investigation by Pomerantz Law Firm
Pomerantz LLP is investigating Alibaba Group Holding Limited (NYSE: BABA) on behalf of investors, alleging potential securities fraud or other unlawful business practices. The investigation follows two major incidents in June and July 2026 that caused significant drops in Alibaba's stock price. Firstly, a report by the Financial Times claimed that Anthropic accused Alibaba of using fake accounts to gain unauthorized access to its AI model Claude. This led to an immediate decline in Alibaba’s ADRs by $7.53 (or 7.34%) over two trading sessions. Then, on July 1, 2026, the U.S. Department of Justice announced a non-prosecution agreement with Alibaba involving a $600 million payment to resolve allegations related to illegal pharmaceutical sales through its platforms. The firm is inviting affected investors to contact them for potential class-action participation.
Tickers: $BABA
Topics: Alibaba class action lawsuit regulatory issues stock price drop